Creatine kinase-myocardial band isoenzyme elevation after percutaneous coronary interventions using sirolimus-eluting stents - 26/08/11
Doi : 10.1016/j.amjcard.2004.02.039
Goran Stankovic, MD a, Alaide Chieffo, MD a, Ioannis Iakovou, MD a, Dejan Orlic, MD a, Nicola Corvaja, MD a, Giuseppe Sangiorgi, MD a, Flavio Airoldi, MD b, Antonio Colombo, MD a, b, ⁎ 
a EMO Centro Cuore Columbus, Milan, Italy
b San Raffaele Hospital, Milan, Italy
*Dr. Colombo's address is: EMO Centro Cuore Columbus, 48 Via Buonarroti, 20145 Milan, Italy.
Abstract |
We evaluated predictors of increased periprocedural creatine kinase-MB isoenzyme levels after implantation of sirolimus-eluting stents with an intent to fully cover the diseased segment. The total stent length per patient (predisposing factor) and elective use of glycoprotein IIb/IIIa (protective factor) were independent predictors of increased creatine kinase-MB isoenzyme levels.
Le texte complet de cet article est disponible en PDF.© 2004
Excerpta Medica Inc. Tous droits réservés.
Vol 93 - N° 11
P. 1397-1401 - juin 2004 Retour au numéro
Article précédent
- Impact of major side branch on periprocedural enzyme elevation and long-term outcome in patients undergoing percutaneous coronary intervention and brachytherapy for in-stent restenosis
- Pramod Kuchulakanti, Seung-Woon Rha, Lowell F Satler, William O Suddath, Augusto D Pichard, Kenneth M Kent, Rajbabu Pakala, Daniel A Canos, Ellen E Pinnow, Ron Waksman
- Reperfusion assessment using myocardial contrast echocardiography in patients with ST-segment elevation acute myocardial infarction
- Michael L Main, Lisa L Kusnetzky, Drusilla Dillon, William C Daniel
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?